Usual care in combination with Project Life Force lowers the risk for actual suicide attempts and improves coping skills in veterans with high risk.

Cannabinoid therapies may alleviate agitation in Alzheimer disease, though somnolence remains a primary safety concern.

Comorbid ASD in youth with ADHD is linked to greater healthcare utilization and distinct medication treatment patterns.

Concussion history is associated with increased odds for tinnitus and greater neurobehavioral outcomes among those with tinnitus.

Middle-aged adults with positive plasma biomarkers for Alzheimer disease show accelerated decline in specific cognitive domains.

School bullying correlates with depression and internet addiction, but emotional resilience serves as a protective factor for adolescents.

The US Department of Health and Human Services Office of Inspector General reports on significant denial rates for post-hospital care.

Standardized diagnostic interviews show moderate-to-substantial test-retest reliability for adult psychiatric and substance use disorders.

Social determinants of health are associated with neurobiologic abnormalities in schizophrenia-spectrum psychotic conditions.

Viloxazine extended-release shows promise for treating adults with ADHD who also experience symptoms of depression and anxiety.

Patient portals and other virtual health care options are expanding, with notable growth in patient portal messaging between 2020 and 2025.

Long-term eptinezumab treatment provides sustained reductions in headache burden for patients with highly refractory chronic migraine.